COLLEEN E RUEGGER
Pharmacy in Greystone Park, NJ
License number
New Jersey 28RI02086200
Issued Date
Jul 25, 1990
Expiration Date
Apr 30, 2017
Category
Pharmacy
Type
Pharmacist
Address
Address
Greystone Park, NJ
Professional information
Dual Acting Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Ne Utral Endopeptidase (Ep) Inhibitor
US Patent:
2010026, Oct 21, 2010
Filed:
Nov 4, 2008
Appl. No.:
12/741251
Inventors:
Suliman Al-Fayoumi - Morristown NJ, US
Jiahui Hu - Bridgewater NJ, US
Natrajan Kumaraperumal - Wayne NJ, US
Alan E. Royce - Saylorsburg PA, US
Colleen Ruegger - Morris Plains NJ, US
Erika A. Zannou - Edison NJ, US
Jiahui Hu - Bridgewater NJ, US
Natrajan Kumaraperumal - Wayne NJ, US
Alan E. Royce - Saylorsburg PA, US
Colleen Ruegger - Morris Plains NJ, US
Erika A. Zannou - Edison NJ, US
International Classification:
A61K 31/41, A61P 9/12, A61P 9/10
US Classification:
514381
Abstract:
Solid oral dosage forms, especially tablets, of a pharmaceutical composition comprising a supramolecular complex can be formed from a direct compression process or a compaction process such as roller compaction. Such solid oral dosage forms feature an immediate release profile that allows for fast release of the therapeutic agent. A particularly useful supramolecular complex is trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3′-methyl-2′-(pentanoyl{2″-(tetrazol-5-ylate)biphenyl-4′-ylmethyl}amino)butyrate]hemipentahydrate.
Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators
US Patent:
2010026, Oct 21, 2010
Filed:
Oct 9, 2008
Appl. No.:
12/682343
Inventors:
Colleen Ruegger - Morris Plains NJ, US
Michael Ambuhl - Rheinfelden, CH
Michael Ambuhl - Rheinfelden, CH
International Classification:
A61K 31/661, A61K 31/138, A61K 31/397, A61P 29/00, A61P 31/12, A61P 9/10, A61P 35/00
US Classification:
514114, 514653, 51421017
Abstract:
The present invention relates to stable compositions comprising a sphingosine 1 phosphate (S1P) receptor modulator, suitable for use as a dosage form. The S1P receptor modulators are typically sphingosine analogues, such as 2-substituted 2-amino-propane-1,3-diol or 2-amino-propanol derivatives, e.g. a compound comprising a group of formula Y.
Solid Pharmaceutical Compositions Comprising A Sip Receptor Agonist And A Sugar Alcohol
US Patent:
2009020, Aug 13, 2009
Filed:
Aug 13, 2008
Appl. No.:
12/191098
Inventors:
Tomoyuki Oomura - Nakatsu-shi, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Edward Royce - Saylorsburg PA, US
Masaki Sasaki - Nakatsu-shi, JP
Tokuhiro Tamura - Fukuoka, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Edward Royce - Saylorsburg PA, US
Masaki Sasaki - Nakatsu-shi, JP
Tokuhiro Tamura - Fukuoka, JP
International Classification:
A61K 31/138
US Classification:
514653
Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.
Solid Pharmaceutical Compositions Comprising A Sip Receptor Agonist And A Sugar Alcohol
US Patent:
2008031, Dec 18, 2008
Filed:
Aug 11, 2008
Appl. No.:
12/189323
Inventors:
Tomoyuki Oomura - Oita, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Edward Royce - Saylorsburg PA, US
Masaki Sasaki - Oita, JP
Tokuhiro Tamura - Fukuoka, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Edward Royce - Saylorsburg PA, US
Masaki Sasaki - Oita, JP
Tokuhiro Tamura - Fukuoka, JP
International Classification:
A61K 31/66, A61K 9/20, A61K 9/48, A61P 41/00, A61P 37/00, A61P 31/12
US Classification:
424452, 514114, 424464, 424451, 424465
Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising:
Organic Compounds
US Patent:
2012028, Nov 15, 2012
Filed:
Jul 19, 2012
Appl. No.:
13/553387
Inventors:
Michael Ambühl - Bridgewater NJ, US
Jutta Beyer - Acton MA, US
Colleen Ruegger - Morris Plains NJ, US
Stephen Valazza - Matawan NJ, US
Jutta Beyer - Acton MA, US
Colleen Ruegger - Morris Plains NJ, US
Stephen Valazza - Matawan NJ, US
International Classification:
A61K 9/00, A61K 9/14, A61K 31/137, A61P 37/06, A61P 29/00, A61P 37/00, A61P 25/28, A61K 47/02, A61K 47/38, A61K 47/34, C07C 215/28, A61K 9/30, C07C 225/16, A61K 9/48, A61K 9/16
US Classification:
424451, 424400, 424490, 514653, 514770, 514781, 564360, 424475
Abstract:
The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition having a coating. In other aspects, rapid disintegrating compositions are provided. In a further aspect, a pharmaceutical composition which is free of sugar alcohols is provided. In another aspect, the invention provides a pharmaceutical composition comprising a coating comprising an S1P receptor modulator.
Organic Compounds
US Patent:
2010004, Feb 18, 2010
Filed:
Sep 25, 2007
Appl. No.:
12/442781
Inventors:
Michael Ambuhl - Rheinfelden, CH
Jutta Beyer - Basel, CH
Begona Carreno-Gomez - Basel, CH
Colleen Ruegger - Morris Plains NJ, US
Stephen Valazza - Matawan NJ, US
Jutta Beyer - Basel, CH
Begona Carreno-Gomez - Basel, CH
Colleen Ruegger - Morris Plains NJ, US
Stephen Valazza - Matawan NJ, US
International Classification:
A61K 9/50, A61K 47/04, A61K 9/32, A61K 9/36, A61K 9/48, A61K 31/135, A61K 9/64, A61P 37/00, A61P 29/00, A61P 41/00
US Classification:
424456, 514769, 514770, 424497, 424482, 424494, 424480, 424463, 514653
Abstract:
The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition having a coating. In other aspects, rapid disintegrating compositions are provided. In a further aspect, a pharmaceutical composition which is free of sugar alcohols is provided. In another aspect, the invention provides a pharmaceutical composition comprising a coating comprising an S1P receptor modulator.
Organic Compounds
US Patent:
2011010, May 5, 2011
Filed:
Jan 10, 2011
Appl. No.:
12/987726
Inventors:
Tomoyuki Oomura - Oita, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Edward Royce - Sayloraburg PA, US
Masaki Sasaki - Oita, JP
Tokuhiro Tamura - Fukuoka, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Edward Royce - Sayloraburg PA, US
Masaki Sasaki - Oita, JP
Tokuhiro Tamura - Fukuoka, JP
International Classification:
A61K 31/137, A61K 47/10, A61K 47/02
US Classification:
514653, 514654, 514772, 514769
Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.
Organic Compounds
US Patent:
2013010, May 2, 2013
Filed:
Dec 20, 2012
Appl. No.:
13/721278
Inventors:
Novartis AG - Basel, CH
Madhusudhan PUDIPEDDI - Edison NJ, US
Colleen RUEGGER - Morris Plains NJ, US
Alan Edward ROYCE - Saylorsburg PA, US
Masaki SASAKI - Oita, JP
Tokuhiro TAMURA - Fukuoka, JP
Madhusudhan PUDIPEDDI - Edison NJ, US
Colleen RUEGGER - Morris Plains NJ, US
Alan Edward ROYCE - Saylorsburg PA, US
Masaki SASAKI - Oita, JP
Tokuhiro TAMURA - Fukuoka, JP
Assignee:
NOVARTIS AG - Basel
International Classification:
A61K 47/10
US Classification:
424400, 514669
Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.
Organic Compounds
US Patent:
2014001, Jan 9, 2014
Filed:
Sep 16, 2013
Appl. No.:
14/027943
Inventors:
Tomoyuki Oomura - Oita, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Edward Royce - Saylorsburg PA, US
Masaki Sasaki - Oita, JP
Tokuhiro Tamura - Fukuoka, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Edward Royce - Saylorsburg PA, US
Masaki Sasaki - Oita, JP
Tokuhiro Tamura - Fukuoka, JP
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/137, A61K 9/48, A61K 9/20
US Classification:
514653
Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.
Organic Compounds
US Patent:
2006027, Dec 7, 2006
Filed:
Apr 6, 2004
Appl. No.:
10/552005
Inventors:
Tomoyuki Oomura - Oita, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Royce - Saylorsburg PA, US
Masaki Sasaki - Oita, JP
Tokuhiro Tamura - Fukuoka, JP
Madhusudhan Pudipeddi - Edison NJ, US
Colleen Ruegger - Morris Plains NJ, US
Alan Royce - Saylorsburg PA, US
Masaki Sasaki - Oita, JP
Tokuhiro Tamura - Fukuoka, JP
International Classification:
A61K 31/138, A61K 9/48, A61K 9/20
US Classification:
424451000, 424464000, 514651000
Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) S1P receptor agonist; and (b) a sugar alcohol.